Literature DB >> 11954004

Decreased aerobic capacity in children with juvenile dermatomyositis.

Jeanne E Hicks1, Bart Drinkard, Ronald M Summers, Lisa G Rider.   

Abstract

OBJECTIVE: To determine whether patients with juvenile dermatomyositis (DM) have limited aerobic capacity compared with healthy controls.
METHODS: Fourteen juvenile DM patients with inactive to moderately active, stable disease (age range 7-17 years) and 14 age- and sex-matched controls performed a maximal exercise test using a cycle ergometer. Oxygen uptake and power were measured at peak exercise (VO(2peak) and W(peak), respectively) and at anaerobic threshold (AT and W(AT)). Juvenile DM disease activity and damage were also assessed.
RESULTS: Patients with juvenile DM had significantly reduced VO(2peak) (19.6 ml O(2)/kg/minute in juvenile DM versus 31.1 ml O(2)/kg/minute in controls), peak heart rate (166 versus 184 beats per minute), W(peak) (1.6 versus 2.7 watts/kg), AT (11.1 versus 18.0 ml O(2)/kg/minute) and W(AT) (0.6 versus 1.4 watts/kg), compared to controls (P <or= 0.05 for each). Aerobic exercise parameters correlated with physician global disease activity and damage, T1-weighted magnetic resonance imaging, and Childhood Myositis Assessment Scale scores (r(s) = 0.58 - 0.82, P <or= 0.05).
CONCLUSION: Patients with juvenile DM with a range of disease activity have a decreased aerobic and work capacity compared to healthy children. Aerobic exercise limitation in juvenile DM correlates best with measures of disease damage (global damage assessment, T1-weighted magnetic resonance imaging, and disease duration). Aerobic exercise testing may be valuable in the assessment of physical endurance, and aerobic training may be indicated as part of the therapeutic regimen in myositis patients with inactive to moderately active, stable disease.

Entities:  

Mesh:

Year:  2002        PMID: 11954004     DOI: 10.1002/art.10237

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 2.  Exercise in inflammatory myopathies, including inclusion body myositis.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

3.  Assessment of the Clinical Effects of Aquatic-based Exercises in the Treatment of Children With Juvenile Dermatomyositis: A 2x2 Controlled-Crossover Trial.

Authors:  Ahmed Samhan; Nermeen Mohamed; Ragab Elnaggar; Waleed Mahmoud
Journal:  Arch Rheumatol       Date:  2019-10-17       Impact factor: 1.472

4.  Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis.

Authors:  Esther A Habers; Marco van Brussel; Anneli C Langbroek-Amersfoort; Annet van Royen-Kerkhof; Tim Takken
Journal:  BMC Musculoskelet Disord       Date:  2012-06-21       Impact factor: 2.362

Review 5.  Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

Authors:  Djamilla K D van der Stap; Lisa G Rider; Helene Alexanderson; Adam M Huber; Bruno Gualano; Patrick Gordon; Janjaap van der Net; Pernille Mathiesen; Liam G Johnson; Floranne C Ernste; Brian M Feldman; Kristin M Houghton; Davinder Singh-Grewal; Abraham Garcia Kutzbach; Li Alemo Munters; Tim Takken
Journal:  J Rheumatol       Date:  2015-11-15       Impact factor: 4.666

6.  Co-expression network analysis reveals the pivotal role of mitochondrial dysfunction and interferon signature in juvenile dermatomyositis.

Authors:  Danli Zhong; Chanyuan Wu; Jingjing Bai; Dong Xu; Xiaofeng Zeng; Qian Wang
Journal:  PeerJ       Date:  2020-02-18       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.